| PERIOD ENDING | 1-Aug-09 | 2-May-09 | 31-Jan-09 | 1-Nov-08 | | Total Revenue | 1,738,504 | 1,980,753 | 3,492,114 | 1,695,746 | | Cost of Revenue | 1,243,098 | 1,438,640 | 2,652,937 | 1,222,317 | | | Gross Profit | 495,406 | 542,113 | 839,177 | 473,429 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 384,773 | 375,832 | 433,285 | 335,722 | | Non Recurring |
-
|
-
| (12,012) | 16,605 | | Others | 39,677 | 37,827 | 38,092 | 35,767 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 70,956 | 128,454 | 379,812 | 85,335 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 462 | (2,345) | 1,377 | 3,672 | | Earnings Before Interest And Taxes | 71,418 | 126,109 | 381,189 | 89,007 | | Interest Expense | 11,737 | 12,198 | 13,708 | 12,479 | | Income Before Tax | 59,681 | 113,911 | 367,481 | 76,528 | | Income Tax Expense | 20,996 | 43,478 | 135,156 | 29,859 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 38,685 | 70,433 | 232,325 | 46,669 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 38,685 | 70,433 | 232,325 | 46,669 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $38,685 | $70,433 | $232,325 | $46,669 |
|
0.16% Nasdaq 0.00%
Income Statement
